TISSUE VIABILITY SOCIETY (TVS)
To promote learning and advance public education in the study of tissue viability and do all such things as may be conducive to improve standards in tissue viability as a multi-professional activity.
Financial health, per its FY2024 accounts
The accounts state that the charity is not currently in deficit and maintains financial reserves equivalent to one year’s running costs. The Trustees declare that they have approved the trustees' report, indicating standard governance procedures were followed for the filing.
What the accounts disclose
“The Gold Open Access business model is primarily supported through author publication fees.” — page 10
“The Trustees are committed to maintaining financial reserves equivalent to one year’s running costs.” — page 12
Register events
- Received assets from another charity (11/09/2020)
Trustees
- Sharon Neillchair
- Ayesha Marshall
- Clare Greenwood
- David Hibbitt
- Heather Hodgson
- Ina Farrelly
- Joanna Swan
- Julie Hewish
- Kate Williams
- Keira Bradley
- Luxmi Dhoonmoon
- Madeleine Coupland
- Peter Worsley
- Samantha Rooney
- Sarah Bradbury
- Sarah Gardner
- Sharon Anne Scattergood
- Victoria Murray
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £304k | £308k |
| 31/12/2023 | £375k | £419k |
| 31/12/2022 | £436k | £365k |
| 31/12/2021 | £324k | £271k |
| 31/12/2020 | £96k | £88k |
Common questions
Is TISSUE VIABILITY SOCIETY (TVS) financially healthy?
Per its FY2024 accounts: The accounts state that the charity is not currently in deficit and maintains financial reserves equivalent to one year’s running costs. The Trustees declare that they have approved the trustees' report, indicating standard governance procedures were followed for the filing.